摘要
目的分析下呼吸道感染患者在使用氧氟沙星与氟罗沙星治疗下的临床效果及经济学方面的评价。方法对2015年1月—2016年6月来内蒙古包钢医院就诊的下呼吸道感染患者136例进行回顾性分析,依照治疗方法的不同将所有患者分为对照组与实验组各68例。对比两组患者的治疗效果及临床治疗成本。结果比较两组患者的治疗效果与不良反应发生率,对照组均高于实验组,但是对比差异没有统计学意义,P>0.05,分析两组患者的治疗成本费用可见实验组低于对照组,差异有统计学意义,P<0.01。结论使用氧氟沙星与氟罗沙星在治疗下呼吸道感染临床效果差异无统计学意义,但是使用氧氟沙星比使用氟罗沙星能节省费用。
Objective To evaluate the clinical effect and economics of patients with lower respiratory tract infection in treatment of ofloxacin and fleroxacin. Methods 136 patients with lower respiratory tract infection in baotou steel hospital of Inner Mongolia from January 2015 to June 2016, were analyzed retrospectively. All patients were divided into control group and experimental group according to different treatment methods, each group had 68 cases. Comparison of two groups of patients with treatment and clinical treatment costs. Results The treatment effect and the incidence of adverse reactions in the two groups were higher than those in the experimental group, but the difference was not statistically significant（P〈0.05）. The cost of treatment in the two groups was significantly lower than that in the control group group, the difference was statistically significant, P〈0.01. Conclusion Using rosa star ofloxacin and fluorine clinical effect in the treatment of lower respiratory tract infection has not significant difference, but the use of levofloxacin than using fluorine rosa star to significant cost savings.
出处
《中国卫生标准管理》
2017年第8期67-69,共3页
China Health Standard Management
关键词
氧氟沙星
氟罗沙星
下呼吸道感染
临床效果
ofloxacin
fleroxacin
lower respiratory tract infection
clinical effect
